Hotline sessions of the 30th European Congress of Cardiology
- PMID: 19339265
- PMCID: PMC2675703
- DOI: 10.1093/eurheartj/ehp095
Hotline sessions of the 30th European Congress of Cardiology
Comment on
-
Hotline sessions of the 30th European Congress of Cardiology.Eur Heart J. 2008 Dec;29(24):3061-4. doi: 10.1093/eurheartj/ehn522. Epub 2008 Nov 25. Eur Heart J. 2008. PMID: 19033262 No abstract available.
References
-
- Bergman H, Rolink AM, Verheugt FWA. Hotline sessions of the 30th European Congress of Cardiology. Eur Heart J. 2008;29:3061–3064. - PubMed
-
- Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94:730–736. - PubMed
-
- Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–772. - PubMed
-
- Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Eibel R, Sabin GV. Prognostic impact of contrast enhanced CMR early after acute ST segment elevation infarction (STEMI) in a regional STEMI network. Herz. 2008;33:136–142. - PubMed
-
- Apex AMI Investigators, Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D, Jr, O'Neill WW, Todaro TG, Vahanian A, Van de Werf F. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. J Am Med Assoc. 2007;297:43–51. - PubMed
